Market Challenges And Opportunities

Global Artificial Vital Organs And Medical Bionics Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of things from one place to another.

However, the COVID-19 pandemic had a negative impact on the global Artificial Vital Organs And Medical Bionics market, owing to reduction in the bed and operating room capacity, which further led to considerable delays in urgent and semi-elective surgical interventions. According to the American College of Surgeons (ACSs) 2021 report, the nature of surgery and anesthesia practices changed during the COVID-19 pandemic as the most elective and non-urgent cases were postponed.

Restraints & Challenges:

Criticism associated with artificial organ transplant

Global Artificial Vital Organs And Medical Bionics Market: Restraint

Criticism associated with artificial organ transplant

Criticism associated with artificial organ transplant is expected to hinder the market growth over the forecast period. Before opting for artificial organ implantation, there are many ethical and physiological aspects to be considered. For instance.

Key players focusing on to develop generalizable knowledge that improves human health or increases understanding of human biology which is expected to drive the market growth over the forecast period.